WHO ICTRP trial
The effect of Montelukast on the treatment of diarrhea and vomiting in children
IRCT20201005048940N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20201005048940N1 |
|---|---|
| Public title | The effect of Montelukast on the treatment of diarrhea and vomiting in children |
| Scientific title | The effect of Montelukast on gastroenteritis-induced azotemia in children admitted to Amirkabir Hospital |
| Primary sponsor | Vice Chancellor for Research, Arak University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Gastroenteritis. Allergic and dietetic gastroenteritis and colitis;K52.2 |
| Interventions | Intervention 1: Intervention group: Prescribing 5mg of Montelukast made by Obaidi company for 5 days and once a day to this group. Intervention 2: Control group: Do not prescribe Montelukast to this group during 5 days of study. |
| Registration date | Oct 8, 2020 |
| Target size | 38 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: